138 related articles for article (PubMed ID: 36473609)
21. Safety of ovarian conservation and fertility preservation in advanced borderline ovarian tumors.
Helpman L; Beiner ME; Aviel-Ronen S; Perri T; Hogen L; Jakobson-Setton A; Ben-Baruch G; Korach J
Fertil Steril; 2015 Jul; 104(1):138-44. PubMed ID: 25956371
[TBL] [Abstract][Full Text] [Related]
22. Long-Term Safety of Letrozole and Gonadotropin Stimulation for Fertility Preservation in Women With Breast Cancer.
Kim J; Turan V; Oktay K
J Clin Endocrinol Metab; 2016 Apr; 101(4):1364-71. PubMed ID: 26751194
[TBL] [Abstract][Full Text] [Related]
23. Prospective study to optimize care and improve knowledge on ovarian function and/or fertility preservation in young breast cancer patients: Results of the pilot phase of the PREgnancy and FERtility (PREFER) study.
Lambertini M; Fontana V; Massarotti C; Poggio F; Dellepiane C; Iacono G; Abate A; Miglietta L; Ferreccio C; Pescio MC; Conte B; Blondeaux E; Bighin C; D'Alonzo A; Vaglica M; Zanardi E; Boccardo F; Ballestrero A; Anserini P; Del Mastro L
Breast; 2018 Oct; 41():51-56. PubMed ID: 30007268
[TBL] [Abstract][Full Text] [Related]
24. The impact of fertility preservation on the timing of breast cancer treatment, recurrence, and survival.
Greer AC; Lanes A; Poorvu PD; Kennedy P; Thomas AM; Partridge AH; Ginsburg ES
Cancer; 2021 Oct; 127(20):3872-3880. PubMed ID: 34161610
[TBL] [Abstract][Full Text] [Related]
25. Fertility preservation in female oncology patients: the influence of the type of cancer on ovarian stimulation response.
Alvarez RM; Ramanathan P
Hum Reprod; 2018 Nov; 33(11):2051-2059. PubMed ID: 27370358
[TBL] [Abstract][Full Text] [Related]
26. [Prognostic factors analysis in patients with ovarian malignant germ cell tumor treated with fertility-preserving surgery].
Yang ZJ; Wei RJ; Li L
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):898-904. PubMed ID: 23324188
[TBL] [Abstract][Full Text] [Related]
27. Influence of breast cancer prognostic factors on oocyte in vitro maturation outcomes performed for urgent fertility preservation.
Raad J; Sonigo C; Benoit A; Cedrin-Durnerin I; Sifer C; Sermondade N; Grynberg M
Hum Reprod; 2022 Jun; 37(7):1480-1488. PubMed ID: 35586947
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of controlled ovarian hyperstimulation with or without letrozole for fertility preservation in breast cancer patients: A multicenter retrospective study.
Goldrat O; De Cooman M; Mailliez A; Delbaere A; D'Orazio E; Demeestere I; Decanter C
Eur J Cancer; 2022 Oct; 174():134-141. PubMed ID: 35998549
[TBL] [Abstract][Full Text] [Related]
29. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study.
Azim AA; Costantini-Ferrando M; Oktay K
J Clin Oncol; 2008 Jun; 26(16):2630-5. PubMed ID: 18509175
[TBL] [Abstract][Full Text] [Related]
30. Long-term post-recurrence survival outcomes in young women receiving fertility-sparing surgery for epithelial ovarian cancer.
Shigeyama M; Yoshihara M; Kitami K; Mogi K; Uno K; Iyoshi S; Tano S; Yoshikawa N; Kajiyama H
Eur J Obstet Gynecol Reprod Biol; 2021 Dec; 267():221-225. PubMed ID: 34826670
[TBL] [Abstract][Full Text] [Related]
31. Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer: A Systematic Review and Meta-analysis.
Munhoz RR; Pereira AA; Sasse AD; Hoff PM; Traina TA; Hudis CA; Marques RJ
JAMA Oncol; 2016 Jan; 2(1):65-73. PubMed ID: 26426573
[TBL] [Abstract][Full Text] [Related]
32. BRCA1/2 gene mutations do not affect the capacity of oocytes from breast cancer candidates for fertility preservation to mature in vitro.
Grynberg M; Dagher Hayeck B; Papanikolaou EG; Sifer C; Sermondade N; Sonigo C
Hum Reprod; 2019 Feb; 34(2):374-379. PubMed ID: 30561604
[TBL] [Abstract][Full Text] [Related]
33. Ovarian preservation for premenopausal women with early-stage endometrial cancer: a Chinese retrospective study.
Lyu T; Guo L; Chen X; Jia N; Gu C; Zhu M; Zhao Y; Liu X; Feng W
J Int Med Res; 2019 Jun; 47(6):2492-2498. PubMed ID: 31020889
[TBL] [Abstract][Full Text] [Related]
34. Utility of gonadotropin-releasing hormone agonists for fertility preservation in young breast cancer patients: the benefit remains uncertain.
Turner NH; Partridge A; Sanna G; Di Leo A; Biganzoli L
Ann Oncol; 2013 Sep; 24(9):2224-35. PubMed ID: 23709175
[TBL] [Abstract][Full Text] [Related]
35. Timing of fertility preservation procedures in a cohort of female patients with cancer.
Jenninga E; Louwe LA; Peters AA; Nortier JW; Hilders CG
Eur J Obstet Gynecol Reprod Biol; 2012 Feb; 160(2):170-3. PubMed ID: 22137982
[TBL] [Abstract][Full Text] [Related]
36. Risk of recurrence and pregnancy outcomes in young women with breast cancer who do and do not undergo fertility preservation.
Wang Y; Tesch ME; Lim C; Xu YH; Lee S; Perdizet K; Yokom D; Warner E; Roberts J; Lohrisch CA
Breast Cancer Res Treat; 2022 Sep; 195(2):201-208. PubMed ID: 35908122
[TBL] [Abstract][Full Text] [Related]
37. Fertility after breast cancer treatment.
Kasum M; Beketić-Orešković L; Peddi PF; Orešković S; Johnson RH
Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():13-8. PubMed ID: 24315568
[TBL] [Abstract][Full Text] [Related]
38. Gonadotrophin stimulation and risk of relapse in breast cancer.
Fredriksson A; Rosenberg E; Einbeigi Z; Bergh C; Strandell A
Hum Reprod Open; 2021; 2021(1):hoaa061. PubMed ID: 33501382
[TBL] [Abstract][Full Text] [Related]
39. Preserving fertility in young women undergoing chemotherapy for early breast cancer; the Maastricht experience.
Vriens IJH; Ter Welle-Butalid EM; de Boer M; de Die-Smulders CEM; Derhaag JG; Geurts SME; van Hellemond IEG; Luiten EJT; Dercksen MW; Lemaire BMD; van Haaren ERM; Vriens BEPJ; van de Wouw AJ; van Riel AMGH; Janssen-Engelen SLE; van de Poel MHW; Schepers-van der Sterren EEM; van Golde RJT; Tjan-Heijnen VCG
Breast Cancer Res Treat; 2020 May; 181(1):77-86. PubMed ID: 32236826
[TBL] [Abstract][Full Text] [Related]
40. Fertility-sparing surgery and oncologic outcome among patients with early-stage ovarian cancer ~propensity score- matched analysis~.
Kajiyama H; Suzuki S; Yoshikawa N; Kawai M; Mizuno K; Yamamuro O; Nagasaka T; Shibata K; Kikkawa F
BMC Cancer; 2019 Dec; 19(1):1235. PubMed ID: 31856753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
